322 related articles for article (PubMed ID: 23827204)
1. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis.
Meadows A; Kaambwa B; Novielli N; Huissoon A; Fry-Smith A; Meads C; Barton P; Dretzke J
Health Technol Assess; 2013 Jul; 17(27):vi, xi-xiv, 1-322. PubMed ID: 23827204
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison.
Dretzke J; Meadows A; Novielli N; Huissoon A; Fry-Smith A; Meads C
J Allergy Clin Immunol; 2013 May; 131(5):1361-6. PubMed ID: 23557834
[TBL] [Abstract][Full Text] [Related]
3. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
Pokladnikova J; Krcmova I; Vlcek J
Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
[TBL] [Abstract][Full Text] [Related]
5. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy.
Nelson H; Cartier S; Allen-Ramey F; Lawton S; Calderon MA
J Allergy Clin Immunol Pract; 2015; 3(2):256-266.e3. PubMed ID: 25609326
[TBL] [Abstract][Full Text] [Related]
6. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review.
Kim JM; Lin SY; Suarez-Cuervo C; Chelladurai Y; Ramanathan M; Segal JB; Erekosima N
Pediatrics; 2013 Jun; 131(6):1155-67. PubMed ID: 23650298
[TBL] [Abstract][Full Text] [Related]
7. Sublingual immunotherapy for allergic rhinitis.
Wilson DR; Torres LI; Durham SR
Cochrane Database Syst Rev; 2003; (2):CD002893. PubMed ID: 12804442
[TBL] [Abstract][Full Text] [Related]
8. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
Tie K; Miller C; Zanation AM; Ebert CS
Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
[TBL] [Abstract][Full Text] [Related]
10. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
[TBL] [Abstract][Full Text] [Related]
11. Specific immunotherapy (SIT) in the treatment of allergic rhinitis.
Hagen A; Gorenoi V; Schönermark MP
GMS Health Technol Assess; 2010 Mar; 6():Doc01. PubMed ID: 21289874
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
Yang J; Lei S
Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of grass pollen subcutaneous immunotherapy (SCIT) compared to sublingual immunotherapy (SLIT) and symptomatic treatment in Austria, Spain, and Switzerland.
Brüggenjürgen B; Reinhold T
J Med Econ; 2018 Apr; 21(4):374-381. PubMed ID: 29271271
[TBL] [Abstract][Full Text] [Related]
14. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis.
Wilson DR; Lima MT; Durham SR
Allergy; 2005 Jan; 60(1):4-12. PubMed ID: 15575924
[TBL] [Abstract][Full Text] [Related]
15. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost.
Dranitsaris G; Ellis AK
J Eval Clin Pract; 2014 Jun; 20(3):225-38. PubMed ID: 24444390
[TBL] [Abstract][Full Text] [Related]
16. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.
Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ
Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933
[TBL] [Abstract][Full Text] [Related]
18. Sublingual or subcutaneous immunotherapy for allergic rhinitis?
Durham SR; Penagos M
J Allergy Clin Immunol; 2016 Feb; 137(2):339-349.e10. PubMed ID: 26853126
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
